[96a5a0]: / output / allTrials / identified / NCT04733820_identified.json

Download this file

591 lines (591 with data), 24.9 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
{
"info": {
"nct_id": "NCT04733820",
"official_title": "Clinical Efficacy of Adjuvant Chemotherapy in Patients With Locally Advanced Cervical Cancer Who Did Not Meet the NCCN Guidelines for Adjuvant Treatment After NACT Combined With Surgery",
"inclusion_criteria": "1. Clinical stage IB3-IIB cervical cancer (FIGO, 2018 standard) with the tumor diameter > 4cm before treatment.\n2. Pathologically confirmed cervical cancer, including cervical squamous cell carcinoma, adenocarcinoma and adenosquamous carcinoma.\n3. Age:18-70 years old.\n4. ECOG status score ≤1;\n5. WBC≥3.5*10^9/L, NEU≥1.5*10^9/L, Platelet≥80×10^9 /L; AST and ALT ≤1.5 times normal upper limit; Total bilirubin ≤1.5 times the upper limit of normal value; serum creatinine and blood urea nitrogen ≤the upper limit of normal value.\n6. Well-compliance and willing to keep in touch.\n7. Able to sign informed consent, including complying with the requirements and restrictions listed in the Informed Consent (ICF) and this protocol.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 70 Years",
"exclusion_criteria": "1. After 2-3 cycles of neoadjuvant chemotherapy, patients do not undergo laparotomic or laparoscopic extensive hysterectomy + pelvic lymph node dissection with cervical cancer foci sealed before dissection of the vagina and without uterine manipulator.\n2. Neoadjuvant chemotherapy regimens are different from postoperative adjuvant therapy regimens.\n3. Postoperative high risk factors: ① lymph node metastasis, ② parauterine infiltration, ③ positive surgical margin.\n4. Postoperative risk factors meet the Sedlis standard of the NCCN guideline.\n5. Participate in other clinical trials.\n6. Severe diseases of other important systems and organs.\n7. Persons without disposing capacity.\n8. Drug and/or alcohol abuse.\n9. Unable or unwilling to sign informed consents.\n10. Not eligible for the study judged by researchers.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "1. Clinical stage IB3-IIB cervical cancer (FIGO, 2018 standard) with the tumor diameter > 4cm before treatment.",
"criterions": [
{
"exact_snippets": "Clinical stage IB3-IIB cervical cancer (FIGO, 2018 standard)",
"criterion": "cervical cancer stage",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 1.3,
"unit": "stage"
},
{
"operator": "<=",
"value": 2.2,
"unit": "stage"
}
]
}
}
]
},
{
"exact_snippets": "tumor diameter > 4cm before treatment",
"criterion": "tumor diameter",
"requirements": [
{
"requirement_type": "size",
"expected_value": {
"operator": ">",
"value": 4,
"unit": "cm"
}
}
]
}
]
},
{
"line": "2. Pathologically confirmed cervical cancer, including cervical squamous cell carcinoma, adenocarcinoma and adenosquamous carcinoma.",
"criterions": [
{
"exact_snippets": "Pathologically confirmed cervical cancer",
"criterion": "cervical cancer",
"requirements": [
{
"requirement_type": "confirmation",
"expected_value": "pathologically confirmed"
}
]
},
{
"exact_snippets": "cervical squamous cell carcinoma",
"criterion": "cervical squamous cell carcinoma",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "adenocarcinoma",
"criterion": "adenocarcinoma",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "adenosquamous carcinoma",
"criterion": "adenosquamous carcinoma",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "3. Age:18-70 years old.",
"criterions": [
{
"exact_snippets": "Age:18-70 years old.",
"criterion": "age",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18,
"unit": "years"
},
{
"operator": "<=",
"value": 70,
"unit": "years"
}
]
}
}
]
}
]
},
{
"line": "4. ECOG status score ≤1;",
"criterions": [
{
"exact_snippets": "ECOG status score ≤1",
"criterion": "ECOG status score",
"requirements": [
{
"requirement_type": "score",
"expected_value": {
"operator": "<=",
"value": 1,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "5. WBC≥3.5*10^9/L, NEU≥1.5*10^9/L, Platelet≥80×10^9 /L; AST and ALT ≤1.5 times normal upper limit; Total bilirubin ≤1.5 times the upper limit of normal value; serum creatinine and blood urea nitrogen ≤the upper limit of normal value.",
"criterions": [
{
"exact_snippets": "WBC≥3.5*10^9/L",
"criterion": "WBC",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 3.5,
"unit": "*10^9/L"
}
}
]
},
{
"exact_snippets": "NEU≥1.5*10^9/L",
"criterion": "NEU",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1.5,
"unit": "*10^9/L"
}
}
]
},
{
"exact_snippets": "Platelet≥80×10^9 /L",
"criterion": "Platelet",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 80,
"unit": "×10^9 /L"
}
}
]
},
{
"exact_snippets": "AST and ALT ≤1.5 times normal upper limit",
"criterion": "AST and ALT",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "times normal upper limit"
}
}
]
},
{
"exact_snippets": "Total bilirubin ≤1.5 times the upper limit of normal value",
"criterion": "Total bilirubin",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "times the upper limit of normal value"
}
}
]
},
{
"exact_snippets": "serum creatinine and blood urea nitrogen ≤the upper limit of normal value",
"criterion": "serum creatinine and blood urea nitrogen",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": "≤the upper limit of normal value"
}
]
}
]
},
{
"line": "6. Well-compliance and willing to keep in touch.",
"criterions": [
{
"exact_snippets": "Well-compliance",
"criterion": "compliance",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "willing to keep in touch",
"criterion": "willingness to maintain contact",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "7. Able to sign informed consent, including complying with the requirements and restrictions listed in the Informed Consent (ICF) and this protocol.",
"criterions": [
{
"exact_snippets": "Able to sign informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
},
{
"exact_snippets": "complying with the requirements and restrictions listed in the Informed Consent (ICF) and this protocol",
"criterion": "compliance with requirements and restrictions",
"requirements": [
{
"requirement_type": "compliance",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 70 Years",
"criterions": [
{
"exact_snippets": "maximum age of 70 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 70,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "1. After 2-3 cycles of neoadjuvant chemotherapy, patients do not undergo laparotomic or laparoscopic extensive hysterectomy + pelvic lymph node dissection with cervical cancer foci sealed before dissection of the vagina and without uterine manipulator.",
"criterions": [
{
"exact_snippets": "After 2-3 cycles of neoadjuvant chemotherapy",
"criterion": "neoadjuvant chemotherapy cycles",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 2,
"unit": "cycles"
},
{
"operator": "<=",
"value": 3,
"unit": "cycles"
}
]
}
}
]
},
{
"exact_snippets": "patients do not undergo laparotomic or laparoscopic extensive hysterectomy",
"criterion": "extensive hysterectomy",
"requirements": [
{
"requirement_type": "procedure",
"expected_value": false
}
]
},
{
"exact_snippets": "patients do not undergo ... pelvic lymph node dissection",
"criterion": "pelvic lymph node dissection",
"requirements": [
{
"requirement_type": "procedure",
"expected_value": false
}
]
},
{
"exact_snippets": "cervical cancer foci sealed before dissection of the vagina",
"criterion": "cervical cancer foci",
"requirements": [
{
"requirement_type": "status",
"expected_value": "sealed before dissection of the vagina"
}
]
},
{
"exact_snippets": "without uterine manipulator",
"criterion": "uterine manipulator",
"requirements": [
{
"requirement_type": "usage",
"expected_value": false
}
]
}
]
},
{
"line": "2. Neoadjuvant chemotherapy regimens are different from postoperative adjuvant therapy regimens.",
"criterions": [
{
"exact_snippets": "Neoadjuvant chemotherapy regimens",
"criterion": "neoadjuvant chemotherapy regimens",
"requirements": [
{
"requirement_type": "difference",
"expected_value": "postoperative adjuvant therapy regimens"
}
]
}
]
},
{
"line": "3. Postoperative high risk factors: ① lymph node metastasis, ② parauterine infiltration, ③ positive surgical margin.",
"criterions": [
{
"exact_snippets": "lymph node metastasis",
"criterion": "lymph node metastasis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "parauterine infiltration",
"criterion": "parauterine infiltration",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "positive surgical margin",
"criterion": "surgical margin",
"requirements": [
{
"requirement_type": "status",
"expected_value": "positive"
}
]
}
]
},
{
"line": "4. Postoperative risk factors meet the Sedlis standard of the NCCN guideline.",
"criterions": [
{
"exact_snippets": "Postoperative risk factors meet the Sedlis standard of the NCCN guideline",
"criterion": "postoperative risk factors",
"requirements": [
{
"requirement_type": "standard",
"expected_value": "Sedlis standard of the NCCN guideline"
}
]
}
]
},
{
"line": "5. Participate in other clinical trials.",
"criterions": [
{
"exact_snippets": "Participate in other clinical trials.",
"criterion": "participation in other clinical trials",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "6. Severe diseases of other important systems and organs.",
"criterions": [
{
"exact_snippets": "Severe diseases of other important systems and organs",
"criterion": "diseases of other important systems and organs",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
}
]
}
]
},
{
"line": "7. Persons without disposing capacity.",
"criterions": [
{
"exact_snippets": "without disposing capacity",
"criterion": "disposing capacity",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "8. Drug and/or alcohol abuse.",
"criterions": [
{
"exact_snippets": "Drug and/or alcohol abuse",
"criterion": "drug abuse",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Drug and/or alcohol abuse",
"criterion": "alcohol abuse",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "9. Unable or unwilling to sign informed consents.",
"criterions": [
{
"exact_snippets": "Unable or unwilling to sign informed consents.",
"criterion": "ability and willingness to sign informed consent",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
},
{
"requirement_type": "willingness",
"expected_value": true
}
]
}
]
},
{
"line": "10. Not eligible for the study judged by researchers.",
"criterions": [
{
"exact_snippets": "Not eligible for the study judged by researchers.",
"criterion": "eligibility",
"requirements": [
{
"requirement_type": "judgment",
"expected_value": "researcher discretion"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}